Wednesday, 18 February 2015

and krensavage too

Krensavage a little late on reporting its buy..

That's another specialist bio fund, and one that likes to buy companies rather than drug prospects.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)